Login
Recent Posts
- FDA approves new Kisunla dosing regimen to lower ARIA-E risk July 11, 2025
- Alzheimer’s Association urging ‘action now’ for awareness month June 6, 2025
- ApoE4 Alzheimer’s Alliance launched as US advocacy group May 2, 2025
- Leqembi approved in EU as treatment for early Alzheimer’s April 21, 2025
- Simufilam fails to meet Phase 3 trial goals; development discontinued April 4, 2025